News

Financial Performance Insights: Greenlight Capital Re 2024

Financial Performance Insights: Greenlight Capital Re 2024

Financial Overview of Greenlight Capital Re for 2024

Greenlight Capital Re, Ltd. (NASDAQ: GLRE) recently provided a detailed analysis of its financial performance for the fourth quarter and the entire year ended December 31, 2024. The Company has made strategic adjustments, restructuring its reportable segments to enhance its efficiency and align better with its innovative multi-pillar approach.

Fourth Quarter Highlights

For the fourth quarter of 2024, Greenlight Re recorded significant changes in its financial metrics compared to the same period in the previous year:

  • Gross premiums written surged by 28.0%, reaching $143.8 million.
  • Net premiums earned increased by 7.8%, totaling $148.1 million.
  • The Company faced a net underwriting loss of $18.0 million, contrasting sharply with a net income of $11.8 million in the fourth quarter of 2023.
  • The combined ratio escalated to 112.1%, compared to a healthier 91.4% from the same period last year.
  • Investment income also saw a decline, resulting in $2.6 million compared to $14.1 million previously.
  • In terms of profitability, the Company reported a net loss of $27.4 million, equating to $(0.81) loss per diluted ordinary share, versus a profit of $17.6 million, or $0.50 per diluted share, from the previous year.

The underwriting loss stemmed primarily from the necessity to bolster reserves for Open Market specialty insurance due to heightened aviation losses linked to geopolitical tensions, specifically the Russia-Ukraine conflict. Additionally, the Company experienced catastrophe losses related to events such as Hurricane Milton and significant marine incidents.

Annual Financial Performance Summary

Across all of 2024, Greenlight Re demonstrated some resilience, though not without challenges:

  • Gross premiums written improved by 9.7% year-over-year, amounting to $698.3 million.
  • Net premiums earned saw a 6.3% increase, bringing the total to $620.0 million.
  • The annual net underwriting loss was recorded at $8.2 million, contrasting with a net underwriting income of $32.0 million from the previous year.
  • The combined ratio for the full year stood at 101.4%, compared to 94.5% in 2023.
  • Total investment income for the year was $79.6 million, improved from $72.1 million previously.
  • Greenlight Re reported an annual net income of $42.8 million, or $1.24 per diluted ordinary share, down from $86.8 million, or $2.50 per diluted share in 2023.
  • Meanwhile, the fully diluted book value per share rose by 7.2%, reaching $17.95, up from $16.74 at the end of the previous year.

The underwriting losses for the year were predominantly tied to reserving for Open Market specialty risks due to ongoing aviation claims influenced by the geopolitical landscape. Catastrophe losses aligned closely with the events that occurred throughout the year, which posed significant financial challenges.

Statements from Leadership

In discussing the results, Greg Richardson, CEO of Greenlight Re, reflected on the firm's achievements despite disappointing financial results for the year. He expressed confidence in the Company's strategic direction, emphasizing its preparedness to generate shareholder value in the years ahead.

David Einhorn, Chairman of the Board, noted the challenges presented during the fourth quarter particularly emanating from the U.S. election outcomes affecting their investment portfolio. However, he highlighted a solid 9.8% return from Solasglas for the year amid the conservative positioning of their investments.

Upcoming Financial Discussions

Greenlight Re is set to host a conference call to further discuss its financial results and strategies on March 11, 2025. Investors and analysts will have the opportunity to gain deeper insights into the Company’s performance and future plans.

Frequently Asked Questions

1. What are the key financial highlights for Greenlight Re in 2024?

Key highlights include an increase in gross premiums written by 9.7% and a net loss of $27.4 million in Q4 associated with heightened underwriting risks.

2. How did the restructuring of reportable segments impact the company's financial reporting?

The restructuring aimed to better align with a multi-pillar strategy, reflecting a more efficient approach in tracking financial performance moving forward.

3. What factors contributed to the underwriting losses in 2024?

Contributory factors include the need for increased reserves for specialty aviation risks linked to geopolitical tensions and significant catastrophe losses.

4. When will Greenlight Re discuss its financial results further?

The Company will provide further insights during a conference call scheduled for March 11, 2025.

5. What is the status of investment income for Greenlight Re?

While total investment income increased to $79.6 million in 2024, it was marked by significant challenges resulting in a notable decline from previous years.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 211

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 163

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 188

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 68

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 85

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 226

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 158

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 237

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 101

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Fund Investors: Understanding Your Rights

Updated Category News Views 110

Understanding the Easterly ROCMuni Fund Situation The Easterly ROCMuni High Income Municipal Bond Fund, formerly known as Principal Street High Income Municipal Fund, has recently come under scrutiny regarding its investment practices. Investors in the fund are encouraged to reach out to legal professionals to discuss potential claims related to significant financial...

Continue Reading
Is Bitcoin Ready for a Breakout Amid Bullish Sentiment?

Updated Category News Views 111

Bitcoin's Current Market Position Bitcoin (BTC/USD) is currently positioned near $115,000, just a day before significant decisions regarding interest rates by the Federal Reserve. Expectations are high, as many anticipate a rate cut of 25 basis points, which is igniting market discussions and predictions. Current Market Sentiment Recent data from Santiment highlights an...

Continue Reading
Nyxoah's Upcoming Presentation at Healthcare Conference Revealed

Updated Category News Views 168

Nyxoah to Present at Healthcare Conference Nyxoah SA, a leader in medical technology focused on treating Obstructive Sleep Apnea (OSA), is poised to showcase its advancements at an upcoming prominent event. The company will take part in the Piper Sandler 36th Annual Healthcare Conference, scheduled for December 4. This notable event is set to provide a platform for Nyxoah...

Continue Reading
Keros Therapeutics Welcomes Dr. Yung H. Chyung as CMO

Updated Category News Views 176

Keros Therapeutics Welcomes New Leadership Keros Therapeutics, Inc. (NASDAQ: KROS) is making waves with the recent appointment of Dr. Yung H. Chyung as their new Chief Medical Officer. This pivotal move signals the company's commitment to advancing its innovative drug development efforts, especially as they gear up for critical clinical milestones. Keros is known for its...

Continue Reading
Nestlé's Strategic Shake-Up: Leadership Changes and Impacts

Updated Category News Views 303

Unexpected Leadership Change at Nestlé In a surprising turn of events, Nestlé has dismissed its Chief Executive Officer, Laurent Freixe, due to his failure to communicate a romantic relationship with an employee who worked under his supervision. This decision highlights the strict adherence to corporate governance rules that Nestlé aims to uphold. Philipp Navratil...

Continue Reading